TY - JOUR
T1 - Regeneration and cell recruitment in an improved heterotopic auxiliary partial liver transplantation model in the rat
AU - Ono, Yoshihiro
AU - Pérez-Gutiérrez, Angelica
AU - Yovchev, Mladen I.
AU - Matsubara, Kentaro
AU - Yokota, Shinichiro
AU - Guzman-Lepe, Jorge
AU - Handa, Kan
AU - De L'Hortet, Alexandra Collin
AU - Thomson, Angus W.
AU - Geller, David A.
AU - Yagi, Hiroshi
AU - Oertel, Michael
AU - Soto-Gutierrez, Alejandro
N1 - Publisher Copyright:
Copyright © 2016 The Authors.
PY - 2017/1
Y1 - 2017/1
N2 - Background. Auxiliary partial liver transplantation (APLT) in humans is a therapeutic modality used especially to treat liver failure in children or congenital metabolic disease. Animal models of APLT have helped to explore therapeutic options. Though many groups have suggested improvements, standardizing the surgical procedure has been challenging. Additionally, the question of whether graft livers are reconstituted by recipient-derived cells after transplantation has been controversial. The aim of this study was to improve experimental APLT in rats and to assess cell recruitment in the liver grafts.Methods. To inhibit recipient liver regeneration and to promote graft regeneration, we treated recipients with retrorsine and added arterial anastomosis. Using green fluorescence protein transgenic rats as recipients, we examined liver resident cell recruitment within graft livers by immuno-fluorescence costaining. Results. In the improved APLT model, we achieved well-regenerated grafts that could maintain regeneration for at least 4 weeks. Regarding the cell recruitment, there was no evidence of recipient-derived hepatocyte, cholangiocyte, or hepatic stellate cell recruitment into the graft. Macrophages/monocytes, however, were consistently recruited into the graft and increased over time, which might be related to inflammatory responses. Very few endothelial cells showed colocalization of markers.Conclusions.We have successfully established an improved rat APLT model with arterial anastomosis as a standard technique. Using this model, we have characterized cell recruitment into the regenerating grafts.
AB - Background. Auxiliary partial liver transplantation (APLT) in humans is a therapeutic modality used especially to treat liver failure in children or congenital metabolic disease. Animal models of APLT have helped to explore therapeutic options. Though many groups have suggested improvements, standardizing the surgical procedure has been challenging. Additionally, the question of whether graft livers are reconstituted by recipient-derived cells after transplantation has been controversial. The aim of this study was to improve experimental APLT in rats and to assess cell recruitment in the liver grafts.Methods. To inhibit recipient liver regeneration and to promote graft regeneration, we treated recipients with retrorsine and added arterial anastomosis. Using green fluorescence protein transgenic rats as recipients, we examined liver resident cell recruitment within graft livers by immuno-fluorescence costaining. Results. In the improved APLT model, we achieved well-regenerated grafts that could maintain regeneration for at least 4 weeks. Regarding the cell recruitment, there was no evidence of recipient-derived hepatocyte, cholangiocyte, or hepatic stellate cell recruitment into the graft. Macrophages/monocytes, however, were consistently recruited into the graft and increased over time, which might be related to inflammatory responses. Very few endothelial cells showed colocalization of markers.Conclusions.We have successfully established an improved rat APLT model with arterial anastomosis as a standard technique. Using this model, we have characterized cell recruitment into the regenerating grafts.
UR - http://www.scopus.com/inward/record.url?scp=85010220012&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85010220012&partnerID=8YFLogxK
U2 - 10.1097/TP.0000000000001511
DO - 10.1097/TP.0000000000001511
M3 - Article
C2 - 28009756
AN - SCOPUS:85010220012
SN - 0041-1337
VL - 101
SP - 92
EP - 100
JO - Transplantation
JF - Transplantation
IS - 1
ER -